The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Turner, J. G.
Right arrow Articles by Yu, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Turner, J. G.
Right arrow Articles by Yu, H.
Right arrowPubmed/NCBI databases
*Substance via MeSH
The Journal of Immunology, 2001, 166: 89-94.
Copyright © 2001 by The American Association of Immunologists

Anti-CD40 Antibody Induces Antitumor and Antimetastatic Effects: The Role of NK Cells1

Joel G. Turner2,*, Alexander L. Rakhmilevich2,{dagger}, Lyudmila Burdelya*, Zane Neal{dagger}, Michael Imboden{dagger}, Paul M. Sondel{dagger} and Hua Yu3,*

* Immunology Program, H. Lee Moffitt Cancer Center and Research Institute, and Department of Medical Microbiology and Immunology, University of South Florida College of Medicine, Tampa, FL 33612; and {dagger} Department of Human Oncology, University of Wisconsin Medical School, Madison, WI 53792

We assessed the effect of the stimulatory anti-CD40 Ab on NK cell activation in vivo and the therapeutic potential of activated NK cells in tumor-bearing mice. Single-dose i.p. injection of the anti-CD40 Ab resulted in production of IL-12 and IFN-{gamma} in vivo, followed by a dramatic increase in NK cell cytolytic activity in PBLs. NK cell activation by anti-CD40 Ab was also observed in CD40 ligand knockout mice. Because NK cells express CD40 ligand but not CD40, our results suggest that NK activation is mediated by increased cytokine production upon CD40 ligation of APCs. Treatment of tumor-bearing mice with anti-CD40 Ab resulted in substantial antitumor and antimetastatic effects in three tumor models. Depletion of NK cells with anti-asialo GM1 Ab reduced or abrogated the observed antitumor effects in all the tested models. These results indicate that a stimulatory CD40 Ab indirectly activates NK cells, which can produce significant antitumor and antimetastatic effects.




This article has been cited by other articles:


Home page
 J. Immunol.Home page
P. Zhou, L. L'italien, D. Hodges, and X. M. Schebye
Pivotal Roles of CD4+ Effector T cells in Mediating Agonistic Anti-GITR mAb-Induced-Immune Activation and Tumor Immunity in CT26 Tumors
J. Immunol., December 1, 2007; 179(11): 7365 - 7375.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. Li, Y. Yan, Y. Lin, D. M. Bullens, O. Rutgeerts, J. Goebels, C. Segers, L. Boon, A. Kasran, R. De Vos, et al.
Rapidly induced, T-cell independent xenoantibody production is mediated by marginal zone B cells and requires help from NK cells
Blood, December 1, 2007; 110(12): 3926 - 3935.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L.-M. Lu, C. C. J. Zavitz, B. Chen, S. Kianpour, Y. Wan, and M. R. Stampfli
Cigarette Smoke Impairs NK Cell-Dependent Tumor Immune Surveillance
J. Immunol., January 15, 2007; 178(2): 936 - 943.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. W. Hellings, A. Kasran, D. Bullens, L. Overbergh, C. Mathieu, H. Heremans, P. Matthys, L. Boon, M. Jorissen, and J. L. Ceuppens
IL-10- and IL-12-Independent Down-Regulation of Allergic Sensitization by Stimulation of CD40 Signaling
J. Immunol., October 15, 2006; 177(8): 5138 - 5144.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
H. D. Lum, I. N. Buhtoiarov, B. E. Schmidt, G. Berke, D. M. Paulnock, P. M. Sondel, and A. L. Rakhmilevich
In vivo CD40 ligation can induce T cell-independent antitumor effects that involve macrophages
J. Leukoc. Biol., June 1, 2006; 79(6): 1181 - 1192.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
K. Kimura, H. Moriwaki, M. Nagaki, M. Saio, Y. Nakamoto, M. Naito, K. Kuwata, and F. V. Chisari
Pathogenic Role of B Cells in Anti-CD40-Induced Necroinflammatory Liver Disease
Am. J. Pathol., March 1, 2006; 168(3): 786 - 795.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
I. N. Buhtoiarov, H. D. Lum, G. Berke, P. M. Sondel, and A. L. Rakhmilevich
Synergistic Activation of Macrophages via CD40 and TLR9 Results in T Cell Independent Antitumor Effects
J. Immunol., January 1, 2006; 176(1): 309 - 318.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
T. Walzer, M. Dalod, S. H. Robbins, L. Zitvogel, and E. Vivier
Natural-killer cells and dendritic cells: "l'union fait la force"
Blood, October 1, 2005; 106(7): 2252 - 2258.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
O. Atochina and D. Harn
LNFPIII/LeX-Stimulated Macrophages Activate Natural Killer Cells via CD40-CD40L Interaction
Clin. Vaccine Immunol., September 1, 2005; 12(9): 1041 - 1049.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
C. Adam, S. King, T. Allgeier, H. Braumuller, C. Luking, J. Mysliwietz, A. Kriegeskorte, D. H. Busch, M. Rocken, and R. Mocikat
DC-NK cell cross talk as a novel CD4+ T-cell-independent pathway for antitumor CTL induction
Blood, July 1, 2005; 106(1): 338 - 344.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
I. N. Buhtoiarov, H. Lum, G. Berke, D. M. Paulnock, P. M. Sondel, and A. L. Rakhmilevich
CD40 Ligation Activates Murine Macrophages via an IFN-{gamma}-Dependent Mechanism Resulting in Tumor Cell Destruction In Vitro
J. Immunol., May 15, 2005; 174(10): 6013 - 6022.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. Burdelya, M. Kujawski, G. Niu, B. Zhong, T. Wang, S. Zhang, M. Kortylewski, K. Shain, H. Kay, J. Djeu, et al.
Stat3 Activity in Melanoma Cells Affects Migration of Immune Effector Cells and Nitric Oxide-Mediated Antitumor Effects
J. Immunol., April 1, 2005; 174(7): 3925 - 3931.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Gendelman, N. Halligan, R. Komorowski, B. Logan, W. J. Murphy, B. R. Blazar, K. A. Pritchard Jr, and W. R. Drobyski
Alpha phenyl-tert-butyl nitrone (PBN) protects syngeneic marrow transplant recipients from the lethal cytokine syndrome occurring after agonistic CD40 antibody administration
Blood, January 1, 2005; 105(1): 428 - 431.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
Z. C. Neal, J. C. Yang, A. L. Rakhmilevich, I. N. Buhtoiarov, H. E. Lum, M. Imboden, J. A. Hank, H. N. Lode, R. A. Reisfeld, S. D. Gillies, et al.
Enhanced Activity of Hu14.18-IL2 Immunocytokine against Murine NXS2 Neuroblastoma when Combined with Interleukin 2 Therapy
Clin. Cancer Res., July 15, 2004; 10(14): 4839 - 4847.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. S. Cragg and M. J. Glennie
Antibody specificity controls in vivo effector mechanisms of anti-CD20 reagents
Blood, April 1, 2004; 103(7): 2738 - 2743.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
V. Bronte, S. Cingarlini, E. Apolloni, P. Serafini, I. Marigo, C. De Santo, B. Macino, O. Marin, and P. Zanovello
Effective Genetic Vaccination with a Widely Shared Endogenous Retroviral Tumor Antigen Requires CD40 Stimulation during Tumor Rejection Phase
J. Immunol., December 15, 2003; 171(12): 6396 - 6405.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. T. van den Broeke, E. Daschbach, E. K. Thomas, G. Andringa, and J. A. Berzofsky
Dendritic Cell-Induced Activation of Adaptive and Innate Antitumor Immunity
J. Immunol., December 1, 2003; 171(11): 5842 - 5852.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
W. J. Murphy, L. Welniak, T. Back, J. Hixon, J. Subleski, N. Seki, J. M. Wigginton, S. E. Wilson, B. R. Blazar, A. M. Malyguine, et al.
Synergistic Anti-Tumor Responses After Administration of Agonistic Antibodies to CD40 and IL-2: Coordination of Dendritic and CD8+ Cell Responses
J. Immunol., March 1, 2003; 170(5): 2727 - 2733.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. L. Tutt, L. O'Brien, A. Hussain, G. R. Crowther, R. R. French, and M. J. Glennie
T Cell Immunity to Lymphoma Following Treatment with Anti-CD40 Monoclonal Antibody
J. Immunol., March 15, 2002; 168(6): 2720 - 2728.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.